By API User
Patients with ADHD will save between $500–1400 in out-of-pocket costs each year thanks to NSW Government reforms allowing GPs to manage and diagnose the condition, according to the Royal Australian College of GPs (RACGP). And with genetic factors estimated to explain 70–80% of ADHD, accessing care through a GP could save a family with three … Continued
By API User
A new landmark report launched today by Omico, confirms precision oncology – the use of genomics to match a person’s tumour DNA to advanced treatments – not only extends the lives of those with incurable cancers, but simultaneously is also creating jobs and fuelling Australia’s economy. Yet without urgent action, many facing a very tough cancer … Continued
By API User
By 2100 Australian and global coral reef communities will be slow to recover, less complex, and dominated by fleshy algae, as high carbon dioxide changes ocean chemistry. An international study published today in Communications Biology has used unique coral reefs in Papua New Guinea to determine the likely impact of ocean acidification on coral reefs in the … Continued
By API User
Cladribine capsules have the potential to be the first oral treatment for people living with rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia Gravis Cladribine capsules has received Fast Track designation and Orphan Drug Designation by the US FDA Merck has established an MG patient council to provide insights on how to best meet the needs … Continued
By API User
– Upon the closing of the private placement, Enlivex will adopt the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. – RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation – built for transparency, automation, … Continued
By API User
Researchers have found Parkinson’s disease causes changes to the blood vessels in the brain. Parkinson’s disease is the second most common neurological disease in Australia, affecting more than 150,000 people. These research findings shift understanding of the disease and may lead to new treatment options. New research has revealed that Parkinson’s disease causes significant and … Continued
By API User
A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors for improved management of the condition. For years doctors have prescribed metformin, an old but common type 2 diabetes medication, to treat insulin resistance in type 1 diabetes. This has … Continued
By API User
The Royal Australian College of GPs (RACGP) has applauded the Federal Government for delivering on its commitment to fund 100 extra Commonwealth-supported places (CSPs) for medical students at 10 universities with a strong commitment to general practice. The announcement represents the first 100 of what will eventually become 150 additional CSPs, with the final 50 … Continued
By API User
A landmark Australian report by Omico will be launched tomorrow (25th Nov) at Parliament House showing that Australians with devastating cancer can have their lives extended when their tumour DNA is matched to advanced treatment, a process called precision oncology, which is simultaneously creating jobs and fuelling our economy. Omico is Australia’s not for … Continued
By API User
Australia’s peak medical specialist training bodies are urging the federal government to establish dedicated regional specialist training centres, warning the current system is failing to produce enough specialist doctors for rural and regional communities. The proposed training hubs would allow doctors to complete the same high-quality specialist training in regional areas that they currently must … Continued
